Oxford Gene Technology
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Begbroke Science Park, Woodstock Road, B...Phone Number
+44 1865845000Website
www.ogt.comRevenue
$21 MillionIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
2
About Oxford Gene Technology
Oxford Gene Technology, founded in 1955 and headquartered in Oxfordshire, UK, provides microarray products and services that enable clinical research and molecular diagnostics in academic, hospital, and government research laboratories all over the world.Explore more
Oxford Gene Technology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Oxford Gene Technology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Oxford Gene Technology had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Oxford Gene Technology has new funding data
Oxford Gene Technology, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Oxford Gene Technology
Product Launch: Get notified when Oxford Gene Technology launches new products
Earning: See what the market has to say on Oxford Gene Technology recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Oxford Gene Technology has recently received funding, and reach out quickly before it becomes old news!
Check out if Oxford Gene Technology is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Oxford Gene Technology as Masked Content
Find more new buyers
Compare Similar Companies to Oxford Gene Technology
Compare insights from companies similar to Oxford Gene Technology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Oxford Gene Technology
$21M
51-200
Private
-
1995
MO
Michael OrnelasDirector, Support & Services (North America)
Company Profile Activity
Activity Insights
Oxford Gene Technology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Oxford Gene Technology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Oxford Gene Technology.
Oxford Gene Technology Tech Stack
A closer look at the technologies used by Oxford Gene Technology
Most Recent Scoops
Hiring Plans
Oxford Gene Technology has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Hiring Plans
Oxford Gene Technology has more open roles in Operations than it has had at any time in the past 9 months.
Hiring Plans
Open Position
Hiring Plans
Oxford Gene Technology News & Media
IVF Market Seeking Excellent Growth by 2021-2030: Oxford Gene Technology, Auxogyn, Vitrolife AB
Edison, NJ -- (SBWIRE) -- 07/12/2021 -- HTF MI Analyst have added a new research study on Title 2021-2030 Report on Global IVF Market by Player, Region, Type, Application and Sales Channel with detailed information of Product Types [ Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER) & Pre-implantation Genetic Diagnosis (PGD)], Applications [Clone, Transgenic, Embryonic Stem Cell Isolation and Culture & Test Tube Baby] & Key Players Such as Vitrolife AB, EMD Serono Inc,Sysmex Inostics and Oxford Gene Technology Plasma and Tissue Sequencing Show Clearance of ctDNA Correlates With Pathologic Complete Response in Breast Cancer Patients During Neoadjuvant Treatment
HAMBURG, Germany and BALTIMORE, Jan. 28, 2020 /PRNewswire/ -- Pathologist Dr. Vincente Peg of the Vall d´Hebron University Hospital (Barcelona Spain) and colleagues have presented a correlation between the clearance of circulating tumor DNA (ctDNA) in HER2-positive or triple-negative...Sysmex Inostics and Oxford Gene Technology Plasma and Tissue Sequencing Show Clearance of ctDNA Correlates With Pathologic Complete Response in Breast Cancer Patients During Neoadjuvant Treatment
Pathologist Dr. Vincente Peg of the Vall d´Hebron University Hospital (Barcelona Spain) and colleagues have presented a correlation between the clearance of circulating tumor DNA (ctDNA) in HER2-positive or triple-negative breast cancer patients undergoing neoadjuvant treatment with a clinical/pathologic complete response at the American Association for Cancer Research (AACR) Advances in Liquid Biopsies conference held in Miami, Florida (USA), January 13-16, 2020. The researchers utilized both a
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oxford Gene Technology
Sign Up For FreeTo access detailed company insights
Oxford Gene Technology, founded in 1955 and headquartered in Oxfordshire, UK, provides microarray products and services that enable clinical research and molecular diagnostics in academic, hospital, and government research laboratories all over the world.... Read More
